{"hands_on_practices": [{"introduction": "A core principle in managing osteoarthritis (OA) is understanding its nature as a disease heavily influenced by mechanical stress. This exercise provides a tangible, quantitative link between a key non-pharmacological intervention—weight loss—and its direct impact on the biomechanical forces driving OA progression. By calculating the cumulative load reduction on a knee joint, you will gain a deeper appreciation for the mechanical pathophysiology of OA, a crucial concept that distinguishes it from primarily inflammatory conditions like rheumatoid arthritis [@problem_id:4973608].", "problem": "A patient with Osteoarthritis (OA) of the knee is counseled on mechanical load modification through weight loss. In contrast to Rheumatoid Arthritis (RA), which is driven primarily by autoimmune inflammation rather than mechanical overload, OA progression is strongly influenced by cumulative joint compressive loads experienced during activities of daily living. Consider a clinically observed and well-tested biomechanical fact: during level-ground walking, the compressive load transmitted through the knee joint per step scales approximately linearly with body mass, so that each $1\\ \\mathrm{kg}$ of body mass lost reduces the per-step knee compressive load by approximately $4\\ \\mathrm{kgf}$ (kilogram-force). Assume that the patient’s gait and walking velocity remain unchanged after weight loss and that the reduction per step is constant across the day.\n\nLet the patient lose $5\\ \\mathrm{kg}$ of body mass and walk $5 \\times 10^{3}$ steps per day. Using the linearity of load with body mass and summation over discrete steps, derive an expression for the cumulative daily knee joint load reduction and compute its value. Express your final answer in kilogram-force per day in scientific notation, and round your answer to three significant figures. State any simplifying assumptions you use explicitly.", "solution": "The problem is assessed to be valid. It is scientifically grounded in established biomechanical principles regarding osteoarthritis, well-posed with sufficient and consistent information, and objective in its presentation. The numerical values provided are realistic and consistent with clinical and research findings.\n\nThis problem requires calculating the cumulative reduction in knee joint compressive load over a day, given a specific weight loss and daily step count. The solution is based on the principle of linear superposition, where the total daily reduction is the sum of the reductions from each individual step.\n\nFirst, we define the variables based on the problem statement:\n- Let $\\Delta m$ be the body mass lost by the patient.\n- Let $N$ be the total number of steps taken per day.\n- Let $k$ be the constant of proportionality that relates the reduction in knee load per step to the body mass lost.\n- Let $\\Delta L_{\\text{step}}$ be the reduction in compressive knee load per step.\n- Let $\\Delta L_{\\text{daily}}$ be the cumulative reduction in compressive knee load per day.\n\nThe problem states that the compressive load transmitted through the knee joint per step scales approximately linearly with body mass. Specifically, each $1\\ \\mathrm{kg}$ of body mass lost reduces the per-step knee compressive load by approximately $4\\ \\mathrm{kgf}$. This gives us the value for the constant $k$:\n$$\nk = \\frac{4\\ \\mathrm{kgf}}{1\\ \\mathrm{kg}} = 4\\ \\mathrm{kgf/kg}\n$$\nThe reduction in load per step, $\\Delta L_{\\text{step}}$, can therefore be expressed as a linear function of the mass lost, $\\Delta m$:\n$$\n\\Delta L_{\\text{step}} = k \\cdot \\Delta m\n$$\nThe problem specifies the following values:\n- Body mass lost, $\\Delta m = 5\\ \\mathrm{kg}$.\n- Steps per day, $N = 5 \\times 10^{3}\\ \\mathrm{steps/day}$.\n\nUsing these values, we can first compute the reduction in load for a single step:\n$$\n\\Delta L_{\\text{step}} = (4\\ \\mathrm{kgf/kg}) \\cdot (5\\ \\mathrm{kg}) = 20\\ \\mathrm{kgf}\n$$\nSo, for each step the patient takes, the compressive load on the knee is reduced by $20\\ \\mathrm{kgf}$.\n\nThe cumulative daily knee joint load reduction, $\\Delta L_{\\text{daily}}$, is the sum of the load reductions over all steps taken in a day. We make the following simplifying assumptions, as specified or implied by the problem:\n1.  The load reduction per step, $\\Delta L_{\\text{step}}$, is constant for all $N$ steps throughout the day. This is explicitly stated.\n2.  The patient's gait pattern and walking velocity remain unchanged, ensuring that the biomechanical relationship described by $k$ remains constant. This is also explicitly stated.\n3.  The given numerical values are treated as having sufficient precision to justify rounding the final answer to three significant figures, as per the problem's instructions.\n\nGiven these assumptions, the cumulative daily reduction is the product of the reduction per step and the total number of steps per day:\n$$\n\\Delta L_{\\text{daily}} = \\sum_{i=1}^{N} \\Delta L_{\\text{step}} = N \\cdot \\Delta L_{\\text{step}}\n$$\nSubstituting the expression for $\\Delta L_{\\text{step}}$, we arrive at the general expression for the cumulative daily load reduction:\n$$\n\\Delta L_{\\text{daily}} = N \\cdot (k \\cdot \\Delta m)\n$$\nNow, we substitute the given numerical values into this expression to compute the final value:\n$$\n\\Delta L_{\\text{daily}} = (5 \\times 10^{3}\\ \\mathrm{steps/day}) \\cdot (20\\ \\mathrm{kgf/step})\n$$\n$$\n\\Delta L_{\\text{daily}} = (5 \\times 10^{3}) \\cdot (20)\\ \\mathrm{kgf/day}\n$$\n$$\n\\Delta L_{\\text{daily}} = 100 \\times 10^{3}\\ \\mathrm{kgf/day}\n$$\n$$\n\\Delta L_{\\text{daily}} = 100000\\ \\mathrm{kgf/day}\n$$\nThe problem requires the answer to be expressed in scientific notation and rounded to three significant figures.\n$$\n100000 = 1.00 \\times 10^5\n$$\nThus, a $5\\ \\mathrm{kg}$ weight loss results in a cumulative reduction of knee load of $1.00 \\times 10^5\\ \\mathrm{kgf}$ over the course of a day with $5000$ steps.", "answer": "$$\\boxed{1.00 \\times 10^{5}}$$", "id": "4973608"}, {"introduction": "Once rheumatoid arthritis (RA) is suspected based on clinical presentation, the next step is to apply formal classification criteria to confirm its likelihood. This practice problem places you in the role of a rheumatologist applying the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. Mastering this point-based system, which integrates joint involvement, serology, inflammatory markers, and symptom duration, is a fundamental skill for accurately identifying patients who will benefit from RA-specific therapy [@problem_id:4973597].", "problem": "A clinician is applying the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) $2010$ classification criteria for rheumatoid arthritis to a patient. The criteria assign points across four domains: joint involvement ($J$), serology ($S$), acute-phase reactants ($A$), and duration of symptoms ($D$). These domains are based on well-tested clinical facts used for classification rather than diagnosis.\n\nJoint involvement ($J$) is scored by the number and type of joints involved, where small joints refer to metacarpophalangeal, proximal interphalangeal, second through fifth metatarsophalangeal, and wrist joints; large joints refer to shoulders, elbows, hips, knees, and ankles. The point assignments are:\n- $1$ large joint: $0$ points.\n- $2$–$10$ large joints: $1$ point.\n- $1$–$3$ small joints (with or without large joints): $2$ points.\n- $4$–$10$ small joints (with or without large joints): $3$ points.\n- $10$ joints with at least $1$ small joint: $5$ points.\n\nSerology ($S$) considers rheumatoid factor (RF) and anti–cyclic citrullinated peptide antibody (anti-CCP), where the upper limit of normal (ULN) is the laboratory’s reference cutoff:\n- Negative RF and negative anti-CCP: $0$ points.\n- Low-positive RF or low-positive anti-CCP (above ULN but not high): $2$ points.\n- High-positive RF or high-positive anti-CCP (typically $3 \\times$ ULN): $3$ points.\n\nAcute-phase reactants ($A$) evaluate C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR):\n- Normal CRP and ESR: $0$ points.\n- Abnormal CRP or ESR: $1$ point.\n\nDuration of symptoms ($D$):\n- $6$ weeks: $0$ points.\n- $\\geq 6$ weeks: $1$ point.\n\nA $47$-year-old patient presents with symmetrical swelling and pain involving the metacarpophalangeal and proximal interphalangeal joints of both hands, with a total of $8$ small joints clinically swollen and tender and no large joints involved. Laboratory testing shows anti-CCP at $4 \\times$ ULN (high-positive) and CRP above ULN (abnormal), while ESR is not available. Symptoms have persisted for $9$ weeks.\n\nUsing the classification framework above, let the total classification score be $$T = J + S + A + D.$$ Compute $T$ for this patient. Provide your final answer as a single integer with no units. No rounding is required. Do not include any interpretation in your final answer; report only the value of $T$.", "solution": "The problem presents a well-defined clinical classification task based on the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) $2010$ criteria for rheumatoid arthritis. The problem statement is scientifically grounded, using established medical criteria, and is well-posed, providing all necessary data to calculate a unique score. The terminology is precise, and the data are internally consistent and plausible. Therefore, the problem is deemed valid and a solution can be derived.\n\nThe objective is to compute the total classification score $T$, which is the sum of scores from four domains: joint involvement ($J$), serology ($S$), acute-phase reactants ($A$), and duration of symptoms ($D$). The total score is given by the formula:\n$$T = J + S + A + D$$\n\nWe will calculate the score for each domain based on the patient's clinical and laboratory data.\n\n1.  **Joint Involvement Score ($J$):**\n    The patient presents with involvement of $8$ small joints (metacarpophalangeal and proximal interphalangeal joints) and no large joints. According to the scoring criteria:\n    - $1$ large joint: $0$ points.\n    - $2$–$10$ large joints: $1$ point.\n    - $1$–$3$ small joints (with or without large joints): $2$ points.\n    - $4$–$10$ small joints (with or without large joints): $3$ points.\n    - $10$ joints with at least $1$ small joint: $5$ points.\n    The patient's presentation of $8$ small joints falls into the category of \"$4$–$10$ small joints\". Therefore, the score for joint involvement is $J = 3$.\n\n2.  **Serology Score ($S$):**\n    The patient's laboratory results show anti–cyclic citrullinated peptide antibody (anti-CCP) at $4 \\times$ the upper limit of normal (ULN), which is specified as \"high-positive\". The serology scoring criteria are:\n    - Negative RF and negative anti-CCP: $0$ points.\n    - Low-positive RF or low-positive anti-CCP: $2$ points.\n    - High-positive RF or high-positive anti-CCP (typically $3 \\times$ ULN): $3$ points.\n    The patient's result of high-positive anti-CCP fulfills the condition for the highest score in this domain. The criterion uses \"or\", so the status of rheumatoid factor (RF) is not required to assign the points. Thus, the serology score is $S = 3$.\n\n3.  **Acute-Phase Reactants Score ($A$):**\n    The patient has an abnormal C-reactive protein (CRP) level (above ULN). The erythrocyte sedimentation rate (ESR) is not available. The criteria for this domain are:\n    - Normal CRP and ESR: $0$ points.\n    - Abnormal CRP or ESR: $1$ point.\n    Since the patient has an abnormal CRP, this condition is met. The criterion uses \"or\", so an abnormal result for either test is sufficient for the point. Therefore, the score for acute-phase reactants is $A = 1$.\n\n4.  **Duration of Symptoms Score ($D$):**\n    The patient's symptoms have persisted for $9$ weeks. The scoring rules for duration are:\n    - $6$ weeks: $0$ points.\n    - $\\geq 6$ weeks: $1$ point.\n    The duration of $9$ weeks is greater than or equal to $6$ weeks ($9 \\ge 6$). Thus, the score for duration is $D = 1$.\n\nFinally, the total classification score $T$ is the sum of the individual scores:\n$$T = J + S + A + D$$\nSubstituting the calculated values:\n$$T = 3 + 3 + 1 + 1$$\n$$T = 8$$\nA total score of $6$ or greater is classified as definite rheumatoid arthritis. The patient's score of $8$ meets this threshold. The problem, however, only asks for the computation of $T$.", "answer": "$$\\boxed{8}$$", "id": "4973597"}, {"introduction": "After classifying a patient with RA, the focus shifts to monitoring disease activity to guide treatment, a concept known as \"treat-to-target.\" This is accomplished using composite indices like the Disease Activity Score in 28 joints (DAS28). This problem challenges you to look inside the \"black box\" of the DAS28, understanding how it combines subjective patient reports and objective data through specific mathematical transformations to produce a single, reliable score for clinical decision-making [@problem_id:4973625].", "problem": "A patient with established rheumatoid arthritis presents for assessment. The standardized $28$-joint counts yield a tender joint count $TJC_{28}=10$ and a swollen joint count $SJC_{28}=8$. The patient global health on a $0$ to $100$ visual analog scale is $GH=50/100$. At the same visit, the erythrocyte sedimentation rate (ESR) is $30\\ \\mathrm{mm/hour}$, and C-reactive protein (CRP) is $20\\ \\mathrm{mg/L}$. Using core definitions of composite disease activity indices in rheumatoid arthritis—namely that Disease Activity Score in $28$ joints (DAS$28$) combines standardized joint counts, an acute-phase reactant, and patient global assessment through transformations that mitigate skew and align scales—identify which option correctly specifies how the inputs should be prepared for DAS$28$ calculation and, based on these data, selects the most plausible disease activity categories for DAS$28$-ESR and DAS$28$-CRP.\n\nA. Use $ \\sqrt{TJC_{28}}$, $ \\sqrt{SJC_{28}}$, and the natural logarithm $ \\ln$ of the acute-phase reactant (either $ \\ln(ESR)$ or $ \\ln(CRP+1)$), include $GH$ on the $0$–$100$ scale; expected categories: high disease activity for both DAS$28$-ESR and DAS$28$-CRP.\n\nB. Use raw counts $TJC_{28}$ and $SJC_{28}$ without transformation, treat $ESR$ or $CRP$ linearly, include $GH$; expected categories: moderate disease activity for DAS$28$-ESR and low disease activity for DAS$28$-CRP.\n\nC. Convert $TJC_{28}$ and $SJC_{28}$ to proportions by dividing by $28$, and use base-$10$ logarithm $ \\log_{10}$ for $ESR$ or $CRP$; expected categories: moderate disease activity for both DAS$28$-ESR and DAS$28$-CRP.\n\nD. Use $ \\sqrt{TJC_{28}}$ and $ \\sqrt{SJC_{28}}$, use $ESR$ and $CRP$ without logarithmic transformation, exclude $GH$; expected categories: high disease activity for DAS$28$-ESR but moderate disease activity for DAS$28$-CRP.", "solution": "## PROBLEM VALIDATION\n\n### Step 1: Extract Givens\nThe problem provides the following data for a patient with established rheumatoid arthritis:\n- Tender joint count ($28$ joints): $TJC_{28} = 10$\n- Swollen joint count ($28$ joints): $SJC_{28} = 8$\n- Patient global health on a visual analog scale: $GH = 50/100$ ($50$ on a $0$ to $100$ scale)\n- Erythrocyte sedimentation rate: $ESR = 30$ $\\mathrm{mm/hour}$\n- C-reactive protein: $CRP = 20$ $\\mathrm{mg/L}$\nThe problem also provides a core definition for composite disease activity indices: \"Disease Activity Score in $28$ joints (DAS$28$) combines standardized joint counts, an acute-phase reactant, and patient global assessment through transformations that mitigate skew and align scales\".\nThe task is to identify the correct method for preparing these inputs for DAS$28$ calculation and to determine the resulting disease activity categories for both DAS$28$-ESR and DAS$28$-CRP.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is assessed against the validation criteria:\n- **Scientifically Grounded**: The problem is based entirely on established and widely used clinical metrics in rheumatology for assessing rheumatoid arthritis (RA) disease activity. The DAS$28$ score is a standard, validated tool. The input variables ($TJC_{28}$, $SJC_{28}$, $GH$, $ESR$, $CRP$) are the standard components of these scores. The provided values are clinically plausible for a patient with active RA.\n- **Well-Posed**: The problem is well-posed. Given the standard formulas for DAS$28$-ESR and DAS$28$-CRP, the provided inputs allow for the calculation of unique numerical scores. The disease activity categories (remission, low, moderate, high) are based on standard, predefined cut-off values, allowing for a unique classification.\n- **Objective**: The problem is stated using objective, standard medical terminology and quantitative data. It asks for the application of a specific, defined formula and classification system, leaving no room for subjective interpretation.\n\nThe problem exhibits none of the invalidity flaws. It is scientifically sound, well-posed, objective, and contains all necessary information for a unique solution.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. The solution process will now proceed.\n\n## SOLUTION DERIVATION\n\n### Principle-Based Derivation\nThe Disease Activity Score in $28$ joints (DAS$28$) is a composite index to measure the disease activity of rheumatoid arthritis. As hinted in the problem statement, it uses mathematical transformations to normalize the distributions of its components. The two most common versions are based on either the erythrocyte sedimentation rate (ESR) or the C-reactive protein (CRP).\n\nThe formula for DAS$28$-ESR is:\n$$DAS28\\text{-}ESR = 0.56 \\times \\sqrt{TJC_{28}} + 0.28 \\times \\sqrt{SJC_{28}} + 0.70 \\times \\ln(ESR) + 0.014 \\times GH$$\nThe formula for DAS$28$-CRP is:\n$$DAS28\\text{-}CRP = 0.56 \\times \\sqrt{TJC_{28}} + 0.28 \\times \\sqrt{SJC_{28}} + 0.36 \\times \\ln(CRP + 1) + 0.014 \\times GH + 0.96$$\nIn both formulas:\n- The tender joint count ($TJC_{28}$) and swollen joint count ($SJC_{28}$) are transformed using the square root function ($ \\sqrt{x} $).\n- The acute-phase reactant ($ESR$ or $CRP$) is transformed using the natural logarithm function ($ \\ln(x) $). For CRP, the term is often written as $\\ln(CRP+1)$ to handle values of $CRP=0$.\n- The patient global health ($GH$) is included linearly on its $0-100$ scale.\n\nThe disease activity is classified using the following standard cut-offs for both scores:\n- High disease activity: $DAS28  5.1$\n- Moderate disease activity: $3.2  DAS28 \\le 5.1$\n- Low disease activity: $2.6 \\le DAS28 \\le 3.2$\n- Remission: $DAS28  2.6$\n\n### Calculation\nUsing the provided data:\n- $TJC_{28} = 10$\n- $SJC_{28} = 8$\n- $GH = 50$\n- $ESR = 30$\n- $CRP = 20$\n\nFirst, calculate the transformed components:\n- $\\sqrt{TJC_{28}} = \\sqrt{10} \\approx 3.162$\n- $\\sqrt{SJC_{28}} = \\sqrt{8} \\approx 2.828$\n- $\\ln(ESR) = \\ln(30) \\approx 3.401$\n- $\\ln(CRP+1) = \\ln(20+1) = \\ln(21) \\approx 3.045$\n\nNow, calculate the DAS$28$ scores:\n**DAS28-ESR:**\n$$DAS28\\text{-}ESR = (0.56 \\times 3.162) + (0.28 \\times 2.828) + (0.70 \\times 3.401) + (0.014 \\times 50)$$\n$$DAS28\\text{-}ESR \\approx 1.771 + 0.792 + 2.381 + 0.700$$\n$$DAS28\\text{-}ESR \\approx 5.644$$\n\n**DAS28-CRP:**\n$$DAS28\\text{-}CRP = (0.56 \\times 3.162) + (0.28 \\times 2.828) + (0.36 \\times 3.045) + (0.014 \\times 50) + 0.96$$\n$$DAS28\\text{-}CRP \\approx 1.771 + 0.792 + 1.096 + 0.700 + 0.96$$\n$$DAS28\\text{-}CRP \\approx 5.319$$\n\n### Classification\n- The DAS$28$-ESR score is $5.644$, which is greater than $5.1$. This corresponds to **high disease activity**.\n- The DAS$28$-CRP score is $5.319$, which is also greater than $5.1$. This also corresponds to **high disease activity**.\n\n### Option-by-Option Analysis\n\n**A. Use $ \\sqrt{TJC_{28}}$, $ \\sqrt{SJC_{28}}$, and the natural logarithm $ \\ln$ of the acute-phase reactant (either $ \\ln(ESR)$ or $ \\ln(CRP+1)$), include $GH$ on the $0$–$100$ scale; expected categories: high disease activity for both DAS$28$-ESR and DAS$28$-CRP.**\n- **Input Preparation**: This correctly describes the mathematical transformations required by the standard DAS$28$ formulas: square root for joint counts and natural logarithm for acute-phase reactants, with linear inclusion of GH.\n- **Expected Categories**: This option correctly predicts that both scores will indicate \"high disease activity\", which matches the results of our calculations ($5.644  5.1$ and $5.319  5.1$).\n- **Verdict**: **Correct**.\n\n**B. Use raw counts $TJC_{28}$ and $SJC_{28}$ without transformation, treat $ESR$ or $CRP$ linearly, include $GH$; expected categories: moderate disease activity for DAS$28$-ESR and low disease activity for DAS$28$-CRP.**\n- **Input Preparation**: This is fundamentally incorrect. The DAS$28$ formula is specifically designed with non-linear transformations (square root and logarithm) to normalize skewed data distributions. Using raw counts and linear values would violate the definition of the score.\n- **Expected Categories**: The predicted categories are inconsistent with a correct calculation.\n- **Verdict**: **Incorrect**.\n\n**C. Convert $TJC_{28}$ and $SJC_{28}$ to proportions by dividing by $28$, and use base-$10$ logarithm $ \\log_{10}$ for $ESR$ or $CRP$; expected categories: moderate disease activity for both DAS$28$-ESR and DAS$28$-CRP.**\n- **Input Preparation**: This describes incorrect transformations. The formula uses square roots of absolute counts, not proportions. It uses the natural logarithm (base $e$), not the base-$10$ logarithm.\n- **Expected Categories**: The predicted categories are inconsistent with a correct calculation.\n- **Verdict**: **Incorrect**.\n\n**D. Use $ \\sqrt{TJC_{28}}$ and $ \\sqrt{SJC_{28}}$, use $ESR$ and $CRP$ without logarithmic transformation, exclude $GH$; expected categories: high disease activity for DAS$28$-ESR but moderate disease activity for DAS$28$-CRP.**\n- **Input Preparation**: This is partially correct about the joint counts but critically flawed. It incorrectly omits the logarithmic transformation for the acute-phase reactants and incorrectly excludes the patient global health ($GH$) component, which is an integral part of the DAS$28$ formula.\n- **Expected Categories**: The premise of the calculation is wrong, making the predicted categories unreliable. Also, the prediction for DAS$28$-CRP (moderate) is factually wrong based on the correct formula.\n- **Verdict**: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "4973625"}]}